Latest Actavis Stories
DUBLIN, Feb. 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mayne Pharma, under which it will divest the U.S.
BOSTON, Feb. 2, 2015 /PRNewswire/ --Columbia Laboratories, Inc.
BOSTON, Jan. 29, 2015 /PRNewswire/ -- Columbia Laboratories, Inc.
- Meeting Dates for Actavis and Allergan Shareholder Meetings Set for March 10, 2015 - DUBLIN and IRVINE, Calif., Jan.
- Vaults Actavis to #1 Position in UK Generics - DUBLIN and LONDON, Jan.
BUDAPEST, Hungary and DUBLIN, Jan. 20, 2015 /PRNewswire/ -- Gedeon Richter Plc.
- Products to be Marketed to Clinics and Hospitals across the United States - DUBLIN, Jan.
- Earnings and Business Update Scheduled for February 18th - DUBLIN, Jan. 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), in advance of the start of the 33(rd) Annual J.P.
DUBLIN and IRVINE, Calif., Jan. 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that the U.S.
- Withering but not falling off, as a blossom that persists on a twig after flowering.